Global Psychiatric Digital Biomarkers Market Size & Outlook

The psychiatric digital biomarkers industry worldwide is expected to reach a projected revenue of US$ 2,285.3 million by 2030. A compound annual growth rate of 23.9% is expected of the worldwide psychiatric digital biomarkers industry from 2024 to 2030.
Revenue, 2023 (US$M)
$521.9
Forecast, 2030 (US$M)
$2,285.3
CAGR, 2024 - 2030
23.9%
Report Coverage
Worldwide

Global psychiatric digital biomarkers market, 2018-2030 (US$M)

Global psychiatric digital biomarkers market highlights

  • The global psychiatric digital biomarkers market generated a revenue of USD 521.9 million in 2023 and is expected to reach USD 2,285.3 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 23.5% by 2030.
  • In terms of segment, wearable accounted for a revenue of USD 521.9 million in 2023.
  • Wearable is the most lucrative type segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2023.

Global data book summary

Market revenue in 2023USD 521.9 million
Market revenue in 2030USD 2,285.3 million
Growth rate23.5% (CAGR from 2023 to 2030)
Largest segmentWearable
Fastest growing segmentWearable
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationWearable

Other key industry trends

  • In terms of revenue, the North America accounted for 58.4% of the global psychiatric digital biomarkers market in 2023.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Psychiatric Digital Biomarkers Market Scope

Psychiatric digital biomarkers market segmentation & scope
Countries
U.S.
Canada
Mexico
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Japan
China
India
Australia
South Korea
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait

Psychiatric Digital Biomarkers Market Companies

Name Profile # Employees HQ Website

Global psychiatric digital biomarkers market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to psychiatric digital biomarkers market will help companies and investors design strategic landscapes.


Wearable was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Global psychiatric digital biomarkers market based on wearable covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global Psychiatric Digital Biomarkers Type Outlook (Revenue, USD Million, 2018-2030)
    • Wearable
    • Mobile based Applications
    • Sensors
    • Others
  • Global Psychiatric Digital Biomarkers Clinical Practise Outlook (Revenue, USD Million, 2018-2030)
    • Diagnostic Psychiatric Digital Biomarkers
    • Monitoring Psychiatric Digital Biomarkers
    • Predictive and Prognostic Psychiatric Digital Biomarkers
    • Others
  • Global Psychiatric Digital Biomarkers End Use Outlook (Revenue, USD Million, 2018-2030)
    • Healthcare companies
    • Healthcare Providers
    • Payers
    • Others

Reasons to subscribe to Global psychiatric digital biomarkers market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global psychiatric digital biomarkers market databook

  • Our clientele includes a mix of psychiatric digital biomarkers market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global psychiatric digital biomarkers market , including forecasts for subscribers. This global databook contains high-level insights into Global psychiatric digital biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global psychiatric digital biomarkers market size, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more